Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management

Malignant melanoma accounts for about 1% of all skin cancers, but it causes most of the skin cancer-related deaths. Circulating tumor DNA (ctDNA) testing is emerging as a relevant tool for the diagnosis and monitoring of cancer. The availability of highly sensitive techniques, including next generat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alessandra Sacco, Laura Forgione, Marianeve Carotenuto, Antonella De Luca, Paolo A. Ascierto, Gerando Botti, Nicola Normanno
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI AG 2020-10-01
Colección:Cancers
Materias:
ctDNA
melanoma
liquid biopsy
prognosis
prediction
patient stratification
Acceso en línea:https://www.mdpi.com/2072-6694/12/10/2914
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares